Table 1.
Clinicopathological characteristics and URG4 expression in the cervical cancer patients
| Number of cases (%) | |
|---|---|
| Age, years | |
| ≥42 | 93 (55.7) |
| <42 | 74 (44.3) |
| Squamous cell carcinoma antigen, ng/ml | |
| ≤1.5 | 97 (58.1) |
| >1.5 | 51 (30.5) |
| No test | 19 (11.4) |
| FIGO stage | |
| Ib1 | 68 (40.7) |
| Ib2 | 59 (35.3) |
| IIa1 | 38 (22.8) |
| IIa2 | 2 (1.2) |
| Tumour size, cm | |
| <4 | 106 (63.5) |
| ≥4 | 61 (36.5) |
| Histological type | |
| Squamous cell carcinoma | 153 (91.6) |
| Adeno cell carcinoma | 14 (8.4) |
| Histological differentiation | |
| Well | 8 (4.8) |
| Moderate | 66 (39.5) |
| Poor | 93 (55.7) |
| Deep stromal invasion | |
| No | 67 (40.1) |
| Yes | 100 (59.9) |
| Lymphovascular space involvement | |
| No | 160 (95.8) |
| Yes | 7 (4.2) |
| Positive parametrium | |
| No | 162 (97) |
| Yes | 5 (2.4) |
| Positive surgical margin | |
| No | 164 (98.2) |
| Yes | 3 (1.8) |
| Vaginal involvement | |
| No | 157 (94.0) |
| Yes | 10 (6.0) |
| T classification | |
| T1b1 | 113 (67.7) |
| T1b2 | 39 (23.4) |
| T2a | 9 (5.4) |
| T2b | 4 (2.4) |
| T4 | 2 (1.2) |
| N classification | |
| N0 | 140 (83.8) |
| N1 | 27 (16.2) |
| M classification | |
| No | 160 (95.8) |
| Yes | 7 (4.2) |
| Concurrent chemotherapy and radiotherapy | |
| No | 59 (62.1) |
| Yes | 36 (37.9) |
| Radiotherapy | |
| No | 49 (68.1) |
| Yes | 23 (31.9) |
| Recurrence | |
| No | 148 (88.6) |
| Yes | 19 (11.4) |
| Vital status (at follow-up) | |
| Alive | 155 (92.8) |
| Dead | 12 (7.2) |
| URG4 expression | |
| Low or no expression | 108 (64.7) |
| High expression | 59 (35.3) |
| 0) | |